Therapeutic plasma exchange in patients with sepsis: Secondary analysis of a cluster‐randomized controlled trial
Journal of Clinical Apheresis · 2023-02 · 38 (1) · 55-62
DOI: 10.1002/jca.22027 ↗Kurz gefasst
Randomisierte kontrollierte Studie in der Zeitschrift Journal of Clinical Apheresis, online erschienen am 31.10.2022. Verfasst von Xiang Luo und 8 weiteren Autor:innen. Beteiligte Einrichtung: Department of Critical Care Medicine, Longyan First Affiliated Hospital of Fujian Medical University, Longyan, China. Hauptthemen laut MEDLINE: Plasma Exchange, Sepsis. Die Arbeit wurde bisher 18-mal zitiert (Crossref) und nennt 25 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0). Gefördert von: Longyan City Science and Technology Plan Project.
Themen: Sepsis
Abstract (Originalsprache)
Introduction
Sepsis is life‐threatening organ dysfunction caused by infection‐related inflammatory response. Therapeutic plasma exchange (TPE) can remove inflammatory mediators and benefit patients in different disease settings. However, no solid evidence showed the efficacy and safety of TPE in sepsis.
Methods
This study was a secondary analysis of a randomized controlled trial. Critically ill patients with sepsis were divided into two groups according to whether treated with TPE. The primary outcome was the delta Sequential Organ Failure Assessment (SOFA) score from days 1 to 7. Secondary outcomes included new‐onset organ failure, intensive care unit (ICU)‐free and alive days to day 28, and 28‐day mortality. Propensity score‐matched (PSM) analysis was applied to control confounders. Analysis of covariance (ANCOVA) and logistic regression were used to assess the association between TPE and selected outcomes.
Results
Among the 2772 critically ill patients enrolled in the trial, 742 patients with sepsis were selected and 22 patients received TPE were matched with 22 control patients. No significant difference was found in the delta SOFA score and 28‐day mortality between TPE group and control group. The ICU‐free and alive days in the TPE group were significantly shorter than the control group.
Conclusions
TPE may be not associated with improvement of organ failure and mortality in critically ill patients with sepsis and may be associated with a prolonged ICU stay.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Critical Care Medicine, Longyan First Affiliated Hospital of Fujian Medical University, Longyan, China.
- Department of Anesthesiology, Longyan First Affiliated Hospital of Fujian Medical University, Longyan, China.
- National Institute of Healthcare Data Science, Nanjing University, Nanjing, China.
- Department of Critical Care Medicine, Jinling Hospital, Medical School of Nanjing University, Nanjing, China.
- Department of Critical Care Medicine, Jinling Hospital, Nanjing Medical University, Nanjing, China.
Förderung
- Longyan City Science and Technology Plan Project
Zitieren
APA
Luo, X., Li, X., Lai, X., Ke, L., Zhou, J., Liu, M., Cao, L., Fu, L., & Chinese Critical Care Nutrition Trials Group (CCCNTG) (2023). Therapeutic plasma exchange in patients with sepsis: Secondary analysis of a cluster‐randomized controlled trial. Journal of Clinical Apheresis, 38(1), 55-62. https://doi.org/10.1002/jca.22027
Vancouver
Luo X, Li X, Lai X, Ke L, Zhou J, Liu M, et al. Therapeutic plasma exchange in patients with sepsis: Secondary analysis of a cluster‐randomized controlled trial. Journal of Clinical Apheresis. 2023;38(1):55-62. doi:10.1002/jca.22027
BibTeX
@article{Luo2023,
author = {Luo, Xiang and Li, Xiaoling and Lai, Xiaoyan and Ke, Lu and Zhou, Jing and Liu, Man and Cao, Longxiang and Fu, Lingyan and Chinese Critical Care Nutrition Trials Group (CCCNTG), Chinese Critical Care Nutrition Trials Group (CCCNTG)},
title = {Therapeutic plasma exchange in patients with sepsis: Secondary analysis of a cluster‐randomized controlled trial},
journal = {Journal of Clinical Apheresis},
year = {2023},
volume = {38},
number = {1},
pages = {55--62},
doi = {10.1002/jca.22027}
}
EUVIMED